Lisata Therapeutics, Inc.LSTANASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | -90.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | -91.50% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +2.32% | +3.71% | +3.57% | +5.01% | +4.30% |
| Weighted Average Shares Diluted Growth | +2.32% | +3.71% | +3.57% | +5.01% | +4.30% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | -22.22% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -36.00% | -39.92% | -40.90% | -43.04% | -49.31% |
| Book Value per Share Growth | -39.98% | -43.14% | -46.92% | -50.89% | -51.84% |
| Debt Growth | -18.45% | -46.51% | -73.30% | -100.00% | -100.00% |
| R&D Expense Growth | -2.09% | -19.72% | -13.38% | -22.93% | -61.53% |
| SG&A Expenses Growth | -0.43% | -3.42% | -8.11% | -12.13% | -31.81% |